Dutogliptin (PHX-1149 free base) is an oral, effective and selective dipeptide-peptide-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus.
Tandutinib is an effective antagonist for FLT3, platelet-derived growth factor receptor (PDGFR), and c-Kit. Tandutinib potently inhibited the activity of FLT3, PDGFR, and c-Kit (IC50: ~200 nM).
5-PA-dUTP (5-Propargylamino-dUTP) is a modified nucleotide, specifically designed with a C5 modification. It serves the purpose of being incorporated into DNA nanoparticles (DNPs) for the efficient delivery of photosensitizers.